Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112769093> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3112769093 abstract "Abstract Neurotoxicity is a common occurrence and a major form of morbidity in adult patients with relapsed or refractory (R/R) diffuse large B cell lymphoma (DLBCL) patients treated with anti-CD19 directed chimeric antigen receptor (CAR) T-cell therapy. Variables related to the incidence and severity of neurotoxicity have been relatively well delineated, but the association between neurotoxicity and the efficacy of CAR T-cell therapy has not been well studied. We performed a retrospective analysis of the outcomes of DLBCL patients who developed neurotoxicity following anti-CD19 CAR T-cell treatment. The analysis included 26 patients with R/R DLBCL who received commercial anti-CD19 CAR T-cell therapy. All patients received a lymphodepleting chemotherapy regimen consisting of fludarabine and cyclophosphamide. Twenty-five patients received axicabtagene ciloleucel, and 1 received tisagenlecleucel. The overall incidence of neurotoxicity was 88%; 31% developed severe neurotoxicity (Grade III-IV by CTCAE). Higher neurotoxicity was associated with better PFS by both CTCAE (CR 2.4 ± 1.1 vs. PD 1.4 ± 1.3, p = 0.051) and CARTOX-10 (CR 3.78 ± 4.6 vs. PD 7.7 ± 3.8, p = 0.044) grading systems. Higher neurotoxicity continued to show a trend at 6, 9, and 12 months by the CTCAE grading system (CR 2.4 ± 1.0 vs. PD 1.7 ± 1.3, p = 0.085), and no patients had disease recurrence after 6 months. In this limited cohort, neurotoxicity severity was paradoxically positively correlated with progression-free survival with commercial CAR T-cell therapy and may therefore indicate an effective therapeutic response." @default.
- W3112769093 created "2020-12-21" @default.
- W3112769093 creator A5001958837 @default.
- W3112769093 creator A5004821244 @default.
- W3112769093 creator A5012428362 @default.
- W3112769093 creator A5016682919 @default.
- W3112769093 creator A5019985302 @default.
- W3112769093 creator A5021958762 @default.
- W3112769093 creator A5057188889 @default.
- W3112769093 creator A5057523501 @default.
- W3112769093 creator A5067291770 @default.
- W3112769093 creator A5072993114 @default.
- W3112769093 creator A5073371884 @default.
- W3112769093 creator A5076423610 @default.
- W3112769093 creator A5084217923 @default.
- W3112769093 creator A5084318140 @default.
- W3112769093 creator A5089893290 @default.
- W3112769093 date "2020-11-01" @default.
- W3112769093 modified "2023-10-16" @default.
- W3112769093 title "NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY" @default.
- W3112769093 doi "https://doi.org/10.1093/neuonc/noaa215.529" @default.
- W3112769093 hasPublicationYear "2020" @default.
- W3112769093 type Work @default.
- W3112769093 sameAs 3112769093 @default.
- W3112769093 citedByCount "0" @default.
- W3112769093 crossrefType "journal-article" @default.
- W3112769093 hasAuthorship W3112769093A5001958837 @default.
- W3112769093 hasAuthorship W3112769093A5004821244 @default.
- W3112769093 hasAuthorship W3112769093A5012428362 @default.
- W3112769093 hasAuthorship W3112769093A5016682919 @default.
- W3112769093 hasAuthorship W3112769093A5019985302 @default.
- W3112769093 hasAuthorship W3112769093A5021958762 @default.
- W3112769093 hasAuthorship W3112769093A5057188889 @default.
- W3112769093 hasAuthorship W3112769093A5057523501 @default.
- W3112769093 hasAuthorship W3112769093A5067291770 @default.
- W3112769093 hasAuthorship W3112769093A5072993114 @default.
- W3112769093 hasAuthorship W3112769093A5073371884 @default.
- W3112769093 hasAuthorship W3112769093A5076423610 @default.
- W3112769093 hasAuthorship W3112769093A5084217923 @default.
- W3112769093 hasAuthorship W3112769093A5084318140 @default.
- W3112769093 hasAuthorship W3112769093A5089893290 @default.
- W3112769093 hasBestOaLocation W31127690931 @default.
- W3112769093 hasConcept C126322002 @default.
- W3112769093 hasConcept C143998085 @default.
- W3112769093 hasConcept C2776694085 @default.
- W3112769093 hasConcept C2776755627 @default.
- W3112769093 hasConcept C2779263901 @default.
- W3112769093 hasConcept C2779491297 @default.
- W3112769093 hasConcept C2781413609 @default.
- W3112769093 hasConcept C29730261 @default.
- W3112769093 hasConcept C71924100 @default.
- W3112769093 hasConcept C90924648 @default.
- W3112769093 hasConceptScore W3112769093C126322002 @default.
- W3112769093 hasConceptScore W3112769093C143998085 @default.
- W3112769093 hasConceptScore W3112769093C2776694085 @default.
- W3112769093 hasConceptScore W3112769093C2776755627 @default.
- W3112769093 hasConceptScore W3112769093C2779263901 @default.
- W3112769093 hasConceptScore W3112769093C2779491297 @default.
- W3112769093 hasConceptScore W3112769093C2781413609 @default.
- W3112769093 hasConceptScore W3112769093C29730261 @default.
- W3112769093 hasConceptScore W3112769093C71924100 @default.
- W3112769093 hasConceptScore W3112769093C90924648 @default.
- W3112769093 hasLocation W31127690931 @default.
- W3112769093 hasLocation W31127690932 @default.
- W3112769093 hasLocation W31127690933 @default.
- W3112769093 hasOpenAccess W3112769093 @default.
- W3112769093 hasPrimaryLocation W31127690931 @default.
- W3112769093 hasRelatedWork W12927781 @default.
- W3112769093 hasRelatedWork W18725558 @default.
- W3112769093 hasRelatedWork W2422317 @default.
- W3112769093 hasRelatedWork W518170 @default.
- W3112769093 hasRelatedWork W5863687 @default.
- W3112769093 hasRelatedWork W9309986 @default.
- W3112769093 hasRelatedWork W9890510 @default.
- W3112769093 hasRelatedWork W17932051 @default.
- W3112769093 hasRelatedWork W18754598 @default.
- W3112769093 hasRelatedWork W814947 @default.
- W3112769093 isParatext "false" @default.
- W3112769093 isRetracted "false" @default.
- W3112769093 magId "3112769093" @default.
- W3112769093 workType "article" @default.